Measurable Residual Disease Testing Following Nonintensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphoma: A Wisconsin Oncology Network Study
Title:
Measurable Residual Disease Testing Following Nonintensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphoma: A Wisconsin Oncology Network Study
Author:
Chang, Julie E. McQuinn, Danielle Hyun, Meredith Kim, KyungMann Kenkre, Vaishalee P. Rajguru, Saurabh A. Pophali, Priyanka A. Endres, Mariah Howard, Mitch Wassenaar, Tim Warren, Ruth Callaway Mattison, Ryan J. Wisinski, Kari B. Fletcher, Christopher D.